Loading…
Physical symptoms, coping styles and quality of life in recurrent ovarian cancer: A prospective population-based study over the last year of life
Abstract Objective The aim of this study was to describe the trajectory of physical symptoms, coping styles and quality of life (QoL) and the relationship between coping and QoL over the last year of life in women with recurrent ovarian cancer. Methods The patient cohort were women recruited to the...
Saved in:
Published in: | Gynecologic oncology 2013-07, Vol.130 (1), p.162-168 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c459t-1c1525ce7d9721778b72982549a13f077bbe06babeddc9917cf4b61dfff5195b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c459t-1c1525ce7d9721778b72982549a13f077bbe06babeddc9917cf4b61dfff5195b3 |
container_end_page | 168 |
container_issue | 1 |
container_start_page | 162 |
container_title | Gynecologic oncology |
container_volume | 130 |
creator | Price, M.A Bell, M.L Sommeijer, D.W Friedlander, M Stockler, M.R deFazio, A Webb, P.M Butow, P.N |
description | Abstract Objective The aim of this study was to describe the trajectory of physical symptoms, coping styles and quality of life (QoL) and the relationship between coping and QoL over the last year of life in women with recurrent ovarian cancer. Methods The patient cohort were women recruited to the Australian Ovarian Cancer Study who subsequently experienced recurrent, invasive ovarian cancer and completed at least one psychosocial assessment (optimism, minimisation, hopelessness/helplessness, QoL) during the last year of life ( n = 217). Results QoL declined sharply from six months before death. Lack of energy was the most prevalent symptom over three measurement periods (67–92%) and also the most severe. Anorexia (36–55%), abdominal swelling (33–58%), nausea (26–47%) and pain (26–43%) all increased in prevalence and severity towards the end of life. Higher optimism ( p = 0.009), higher minimisation ( p = 0.003) and lower helplessness/hopelessness ( p = 0.03) at baseline were significant predictors of subsequent higher QoL. Conclusions Progressive deterioration in quality of life may be an indicator of death within about six months and therefore should be an important consideration in decisions about subsequent treatment. Coping styles which independently predicted subsequent changes in QoL could potentially be targeted by interventions to minimise worsening QoL. |
doi_str_mv | 10.1016/j.ygyno.2013.03.031 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1369233766</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0090825813002187</els_id><sourcerecordid>1369233766</sourcerecordid><originalsourceid>FETCH-LOGICAL-c459t-1c1525ce7d9721778b72982549a13f077bbe06babeddc9917cf4b61dfff5195b3</originalsourceid><addsrcrecordid>eNqFUk2LFDEUDKK44-ovECRHD_aYj0mnIygsi1-woKCeQzr9ejdjJulN0gP9M_zHpp1dD16EB7lU1UtVPYSeU7KlhLav99vleglxywjlW7IOfYA2lCjRtJ1QD9GGEEWajonuDD3JeU8I4YSyx-iMcSE7wbsN-vX1ZsnOGo_zcphKPORX2MbJhWucy-IhYxMGfDsb78qC44i9GwG7gBPYOSUIBcejSc4EbE2wkN7gCzylmCewxR0BT3GavSkuhqY3GYYqOw9V6QgJlxvA3uSCFzDpXvwpejQan-HZ3XuOfnx4__3yU3P15ePny4urxu6EKg21VDBhQQ5KMipl10umqtedMpSPRMq-B9L2podhsEpRacdd39JhHEdBlej5OXp50q2_vZ0hF31w2YL3JkCcs6a8VYxz2bYVyk9QW43lBKOekjuYtGhK9NqF3us_Xei1C03WoZX14m7B3B9g-Mu5D78C3p4AUG0eHSSdrYMa4uBqukUP0f1nwbt_-Na7sJb5ExbI-zinUBPUVGemif62nsN6DZQTwmgn-W9YjrO3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1369233766</pqid></control><display><type>article</type><title>Physical symptoms, coping styles and quality of life in recurrent ovarian cancer: A prospective population-based study over the last year of life</title><source>Elsevier</source><creator>Price, M.A ; Bell, M.L ; Sommeijer, D.W ; Friedlander, M ; Stockler, M.R ; deFazio, A ; Webb, P.M ; Butow, P.N</creator><creatorcontrib>Price, M.A ; Bell, M.L ; Sommeijer, D.W ; Friedlander, M ; Stockler, M.R ; deFazio, A ; Webb, P.M ; Butow, P.N ; The Australian Ovarian Cancer Study Group ; The Australian Ovarian Cancer Study Quality of Life Study Investigators ; Australian Ovarian Cancer Study Group ; Australian Ovarian Cancer Study Quality of Life Study Investigators</creatorcontrib><description>Abstract Objective The aim of this study was to describe the trajectory of physical symptoms, coping styles and quality of life (QoL) and the relationship between coping and QoL over the last year of life in women with recurrent ovarian cancer. Methods The patient cohort were women recruited to the Australian Ovarian Cancer Study who subsequently experienced recurrent, invasive ovarian cancer and completed at least one psychosocial assessment (optimism, minimisation, hopelessness/helplessness, QoL) during the last year of life ( n = 217). Results QoL declined sharply from six months before death. Lack of energy was the most prevalent symptom over three measurement periods (67–92%) and also the most severe. Anorexia (36–55%), abdominal swelling (33–58%), nausea (26–47%) and pain (26–43%) all increased in prevalence and severity towards the end of life. Higher optimism ( p = 0.009), higher minimisation ( p = 0.003) and lower helplessness/hopelessness ( p = 0.03) at baseline were significant predictors of subsequent higher QoL. Conclusions Progressive deterioration in quality of life may be an indicator of death within about six months and therefore should be an important consideration in decisions about subsequent treatment. Coping styles which independently predicted subsequent changes in QoL could potentially be targeted by interventions to minimise worsening QoL.</description><identifier>ISSN: 0090-8258</identifier><identifier>EISSN: 1095-6859</identifier><identifier>DOI: 10.1016/j.ygyno.2013.03.031</identifier><identifier>PMID: 23578538</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adaptation, Psychological ; Coping ; End of life ; Female ; Hematology, Oncology and Palliative Medicine ; Humans ; Middle Aged ; Neoplasm Recurrence, Local - physiopathology ; Neoplasm Recurrence, Local - psychology ; Neoplasm Recurrence, Local - therapy ; Obstetrics and Gynecology ; Ovarian cancer ; Ovarian Neoplasms - physiopathology ; Ovarian Neoplasms - psychology ; Ovarian Neoplasms - therapy ; Prospective Studies ; Psychosocial ; Quality of Life ; Symptoms</subject><ispartof>Gynecologic oncology, 2013-07, Vol.130 (1), p.162-168</ispartof><rights>2013</rights><rights>Crown Copyright © 2013. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c459t-1c1525ce7d9721778b72982549a13f077bbe06babeddc9917cf4b61dfff5195b3</citedby><cites>FETCH-LOGICAL-c459t-1c1525ce7d9721778b72982549a13f077bbe06babeddc9917cf4b61dfff5195b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23578538$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Price, M.A</creatorcontrib><creatorcontrib>Bell, M.L</creatorcontrib><creatorcontrib>Sommeijer, D.W</creatorcontrib><creatorcontrib>Friedlander, M</creatorcontrib><creatorcontrib>Stockler, M.R</creatorcontrib><creatorcontrib>deFazio, A</creatorcontrib><creatorcontrib>Webb, P.M</creatorcontrib><creatorcontrib>Butow, P.N</creatorcontrib><creatorcontrib>The Australian Ovarian Cancer Study Group</creatorcontrib><creatorcontrib>The Australian Ovarian Cancer Study Quality of Life Study Investigators</creatorcontrib><creatorcontrib>Australian Ovarian Cancer Study Group</creatorcontrib><creatorcontrib>Australian Ovarian Cancer Study Quality of Life Study Investigators</creatorcontrib><title>Physical symptoms, coping styles and quality of life in recurrent ovarian cancer: A prospective population-based study over the last year of life</title><title>Gynecologic oncology</title><addtitle>Gynecol Oncol</addtitle><description>Abstract Objective The aim of this study was to describe the trajectory of physical symptoms, coping styles and quality of life (QoL) and the relationship between coping and QoL over the last year of life in women with recurrent ovarian cancer. Methods The patient cohort were women recruited to the Australian Ovarian Cancer Study who subsequently experienced recurrent, invasive ovarian cancer and completed at least one psychosocial assessment (optimism, minimisation, hopelessness/helplessness, QoL) during the last year of life ( n = 217). Results QoL declined sharply from six months before death. Lack of energy was the most prevalent symptom over three measurement periods (67–92%) and also the most severe. Anorexia (36–55%), abdominal swelling (33–58%), nausea (26–47%) and pain (26–43%) all increased in prevalence and severity towards the end of life. Higher optimism ( p = 0.009), higher minimisation ( p = 0.003) and lower helplessness/hopelessness ( p = 0.03) at baseline were significant predictors of subsequent higher QoL. Conclusions Progressive deterioration in quality of life may be an indicator of death within about six months and therefore should be an important consideration in decisions about subsequent treatment. Coping styles which independently predicted subsequent changes in QoL could potentially be targeted by interventions to minimise worsening QoL.</description><subject>Adaptation, Psychological</subject><subject>Coping</subject><subject>End of life</subject><subject>Female</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local - physiopathology</subject><subject>Neoplasm Recurrence, Local - psychology</subject><subject>Neoplasm Recurrence, Local - therapy</subject><subject>Obstetrics and Gynecology</subject><subject>Ovarian cancer</subject><subject>Ovarian Neoplasms - physiopathology</subject><subject>Ovarian Neoplasms - psychology</subject><subject>Ovarian Neoplasms - therapy</subject><subject>Prospective Studies</subject><subject>Psychosocial</subject><subject>Quality of Life</subject><subject>Symptoms</subject><issn>0090-8258</issn><issn>1095-6859</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqFUk2LFDEUDKK44-ovECRHD_aYj0mnIygsi1-woKCeQzr9ejdjJulN0gP9M_zHpp1dD16EB7lU1UtVPYSeU7KlhLav99vleglxywjlW7IOfYA2lCjRtJ1QD9GGEEWajonuDD3JeU8I4YSyx-iMcSE7wbsN-vX1ZsnOGo_zcphKPORX2MbJhWucy-IhYxMGfDsb78qC44i9GwG7gBPYOSUIBcejSc4EbE2wkN7gCzylmCewxR0BT3GavSkuhqY3GYYqOw9V6QgJlxvA3uSCFzDpXvwpejQan-HZ3XuOfnx4__3yU3P15ePny4urxu6EKg21VDBhQQ5KMipl10umqtedMpSPRMq-B9L2podhsEpRacdd39JhHEdBlej5OXp50q2_vZ0hF31w2YL3JkCcs6a8VYxz2bYVyk9QW43lBKOekjuYtGhK9NqF3us_Xei1C03WoZX14m7B3B9g-Mu5D78C3p4AUG0eHSSdrYMa4uBqukUP0f1nwbt_-Na7sJb5ExbI-zinUBPUVGemif62nsN6DZQTwmgn-W9YjrO3</recordid><startdate>20130701</startdate><enddate>20130701</enddate><creator>Price, M.A</creator><creator>Bell, M.L</creator><creator>Sommeijer, D.W</creator><creator>Friedlander, M</creator><creator>Stockler, M.R</creator><creator>deFazio, A</creator><creator>Webb, P.M</creator><creator>Butow, P.N</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130701</creationdate><title>Physical symptoms, coping styles and quality of life in recurrent ovarian cancer: A prospective population-based study over the last year of life</title><author>Price, M.A ; Bell, M.L ; Sommeijer, D.W ; Friedlander, M ; Stockler, M.R ; deFazio, A ; Webb, P.M ; Butow, P.N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c459t-1c1525ce7d9721778b72982549a13f077bbe06babeddc9917cf4b61dfff5195b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adaptation, Psychological</topic><topic>Coping</topic><topic>End of life</topic><topic>Female</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local - physiopathology</topic><topic>Neoplasm Recurrence, Local - psychology</topic><topic>Neoplasm Recurrence, Local - therapy</topic><topic>Obstetrics and Gynecology</topic><topic>Ovarian cancer</topic><topic>Ovarian Neoplasms - physiopathology</topic><topic>Ovarian Neoplasms - psychology</topic><topic>Ovarian Neoplasms - therapy</topic><topic>Prospective Studies</topic><topic>Psychosocial</topic><topic>Quality of Life</topic><topic>Symptoms</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Price, M.A</creatorcontrib><creatorcontrib>Bell, M.L</creatorcontrib><creatorcontrib>Sommeijer, D.W</creatorcontrib><creatorcontrib>Friedlander, M</creatorcontrib><creatorcontrib>Stockler, M.R</creatorcontrib><creatorcontrib>deFazio, A</creatorcontrib><creatorcontrib>Webb, P.M</creatorcontrib><creatorcontrib>Butow, P.N</creatorcontrib><creatorcontrib>The Australian Ovarian Cancer Study Group</creatorcontrib><creatorcontrib>The Australian Ovarian Cancer Study Quality of Life Study Investigators</creatorcontrib><creatorcontrib>Australian Ovarian Cancer Study Group</creatorcontrib><creatorcontrib>Australian Ovarian Cancer Study Quality of Life Study Investigators</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gynecologic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Price, M.A</au><au>Bell, M.L</au><au>Sommeijer, D.W</au><au>Friedlander, M</au><au>Stockler, M.R</au><au>deFazio, A</au><au>Webb, P.M</au><au>Butow, P.N</au><aucorp>The Australian Ovarian Cancer Study Group</aucorp><aucorp>The Australian Ovarian Cancer Study Quality of Life Study Investigators</aucorp><aucorp>Australian Ovarian Cancer Study Group</aucorp><aucorp>Australian Ovarian Cancer Study Quality of Life Study Investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Physical symptoms, coping styles and quality of life in recurrent ovarian cancer: A prospective population-based study over the last year of life</atitle><jtitle>Gynecologic oncology</jtitle><addtitle>Gynecol Oncol</addtitle><date>2013-07-01</date><risdate>2013</risdate><volume>130</volume><issue>1</issue><spage>162</spage><epage>168</epage><pages>162-168</pages><issn>0090-8258</issn><eissn>1095-6859</eissn><abstract>Abstract Objective The aim of this study was to describe the trajectory of physical symptoms, coping styles and quality of life (QoL) and the relationship between coping and QoL over the last year of life in women with recurrent ovarian cancer. Methods The patient cohort were women recruited to the Australian Ovarian Cancer Study who subsequently experienced recurrent, invasive ovarian cancer and completed at least one psychosocial assessment (optimism, minimisation, hopelessness/helplessness, QoL) during the last year of life ( n = 217). Results QoL declined sharply from six months before death. Lack of energy was the most prevalent symptom over three measurement periods (67–92%) and also the most severe. Anorexia (36–55%), abdominal swelling (33–58%), nausea (26–47%) and pain (26–43%) all increased in prevalence and severity towards the end of life. Higher optimism ( p = 0.009), higher minimisation ( p = 0.003) and lower helplessness/hopelessness ( p = 0.03) at baseline were significant predictors of subsequent higher QoL. Conclusions Progressive deterioration in quality of life may be an indicator of death within about six months and therefore should be an important consideration in decisions about subsequent treatment. Coping styles which independently predicted subsequent changes in QoL could potentially be targeted by interventions to minimise worsening QoL.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>23578538</pmid><doi>10.1016/j.ygyno.2013.03.031</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0090-8258 |
ispartof | Gynecologic oncology, 2013-07, Vol.130 (1), p.162-168 |
issn | 0090-8258 1095-6859 |
language | eng |
recordid | cdi_proquest_miscellaneous_1369233766 |
source | Elsevier |
subjects | Adaptation, Psychological Coping End of life Female Hematology, Oncology and Palliative Medicine Humans Middle Aged Neoplasm Recurrence, Local - physiopathology Neoplasm Recurrence, Local - psychology Neoplasm Recurrence, Local - therapy Obstetrics and Gynecology Ovarian cancer Ovarian Neoplasms - physiopathology Ovarian Neoplasms - psychology Ovarian Neoplasms - therapy Prospective Studies Psychosocial Quality of Life Symptoms |
title | Physical symptoms, coping styles and quality of life in recurrent ovarian cancer: A prospective population-based study over the last year of life |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T14%3A34%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Physical%20symptoms,%20coping%20styles%20and%20quality%20of%20life%20in%20recurrent%20ovarian%20cancer:%20A%20prospective%20population-based%20study%20over%20the%20last%20year%20of%20life&rft.jtitle=Gynecologic%20oncology&rft.au=Price,%20M.A&rft.aucorp=The%20Australian%20Ovarian%20Cancer%20Study%20Group&rft.date=2013-07-01&rft.volume=130&rft.issue=1&rft.spage=162&rft.epage=168&rft.pages=162-168&rft.issn=0090-8258&rft.eissn=1095-6859&rft_id=info:doi/10.1016/j.ygyno.2013.03.031&rft_dat=%3Cproquest_cross%3E1369233766%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c459t-1c1525ce7d9721778b72982549a13f077bbe06babeddc9917cf4b61dfff5195b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1369233766&rft_id=info:pmid/23578538&rfr_iscdi=true |